Abbott Laboratories Ranks 75th in Trading Volume with $894 Million as Stock Price Rises

On April 14, 2025, Abbott Laboratories (ABT) saw a trading volume of $894 million, ranking 75th in the day's stock market activity. The company's stock price increased by 0.85%, marking the second consecutive day of gains, with a total increase of 2.78% over the past two days.

Stifel Nicolaus analyst Rick Wise maintained a Buy rating on Abbott Laboratories and set a price target of $135.00, reflecting confidence in the company's future performance.

Abbott's first-quarter earnings report is anticipated, with a particular focus on its Medical Devices segment. The Structural Heart, Rhythm Management, and Neuromodulation businesses are expected to have driven significant growth.

Investors are closely watching Abbott's performance, as it accounts for approximately 18.86% of the total assets in the iShares U.S. Medical Devices ETF, highlighting its substantial influence in the medical devices sector.